Attached files
file | filename |
---|---|
8-K - CURRENT REPORT - Exactus, Inc. | exdi8k_jan252019.htm |
Exhibit 99.1
Exactus Appoints New Members to Its Board of Directors
Adds Expertise in Finance Healthcare & Operations
Exactus Inc. (OTCQB: EXDI) a healthcare company pursuing
opportunities in Hemp derived, Cannabidiol (CBD) products and point
of care diagnostics, is pleased to announce the
election of three new board members including Kevin Esval, Jeffrey
Thompson and Ken Puzder. With these three additions, the Exactus
Board of Directors expands to five.
Philip
Young, Chairman & CEO of Exactus said “We are honored to
welcome Messieurs Esval, Thompson and Puzder to our board. Their
extensive and varied background will support Exactus from
operations to finance as we enter into the rapidly growing CBD
market.” Young further commented, “The quality of the
board speaks volumes to where the company is
headed.”
Kevin
Esval currently serves as Executive Managing Director of
VelocityHealth Securities. Prior to founding VelocityHealth, Mr.
Esval served as a divisional SVP and COO for UnitedHealth Group
where he was instrumental in growing his division from startup to
$400 million in revenue.
Jeffrey
Thompson is the CEO and Founder of Red Cat Propware Inc., a
provider of cloud-based analytics, storage, and services for drone
aircraft. Mr. Thompson founded Towerstream Corp. which became
publicly traded on the NASDAQ in June 2007 as well as EdgeNet Inc.,
a privately held Internet service provider which was sold to
Citadel Broadcasting Corporation in 1997.
Kenneth
Puzder serves as the Chief Financial Officer of Ceed2Med, our
largest shareholder. Mr. Puzder previously served in various
positions with the Arby’s Restaurant Group
(“ARG”) family of companies, including CFO of AFA
Service Corporation. “In speaking for my fellow board
members, I would like to say how excited we are to add our
financial, healthcare and executive expertise to help guide
management in this exciting opportunity”.
For information about our products and availability please call
804-205-5036 or email,
cbd@exactusinc.com.
About Exactus:
Exactus,
Inc., is a healthcare company pursuing opportunities in two
distinct business segments, Hemp derived, Cannabidiol, which is
more commonly referred to as CBD. Industrial hemp is a type of
cannabis, defined by the federal government as having THC
(tetrahydrocannabinol) content of 0.3 percent or less. That amount
has not been shown to make a person feel “high.” THC is
the psychoactive compound found in cannabis. The company is also
developing point of care diagnostics.
Forward Looking Statements:
This
press release includes forward-looking statements. Such
forward-looking statements include those that express plans,
anticipation, intent, contingency, goals, targets or future
development and/or otherwise are not statements of historical fact.
These forward-looking statements are based on our current
expectations and projections about future events and they are
subject to risks and uncertainties known and unknown that could
cause actual results and developments to differ materially from
those expressed or implied in such statements. Such risks and
uncertainties include, but are not limited to, the impact of
competitive firms, the ability to meet regulatory requirements, the
ability to manage growth, the ability to acquire and retain
clientele, acquisitions of technology, equipment, or human
resources, the ability to access new capital, the effect of
economic business conditions, and the ability to attract and retain
skilled personnel. We are not obligated to revise or update any
forward-looking statements in order to reflect events or
circumstances that may arise after the date of this press
release.
For more information:
Company
Contacts:
Corporate
Communications Contact:
Tim
Ryan, EVP, Director
tryan@exactusinc.com
646.342.6199
Philip
J. Young, Chairman and CEO
pyoung@exactusinc.com